Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06845852 · ClinicalTrials.gov registry record · Phase 1
A Phase 1 Mass Balance Study of Varegacestat
A Phase 1 study, sponsored by Immunome.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT06845852 is a Phase 1 study that has completed, run by Immunome. The registered enrollment target is 6 participants.
The verdict
NCT06845852, a Phase 1 study, has completed, sponsored by Immunome.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This clinical study is designed to study the mass balance of a single dose of varegacestat in healthy male participants.
Interventions
- DRUG varegacestat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-02-25 |
| Est. Completion | 2025-03-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06845852
The ClinicalTrials.gov registry entry for NCT06845852 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Immunome, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which varegacestat is the first listed.
NCT06845852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06845852 about?
NCT06845852 is a clinical study titled "A Phase 1 Mass Balance Study of Varegacestat". This clinical study is designed to study the mass balance of a single dose of varegacestat in healthy male participants.
What is the current status of trial NCT06845852?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2025-02-25. Estimated completion is 2025-03-26.
What interventions are being tested in trial NCT06845852?
The interventions under investigation include: varegacestat (DRUG).
Who is sponsoring clinical trial NCT06845852?
This trial is sponsored by Immunome, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.